Last Updated: Monday, April 03, 2023
Highmark has partnered with eviCore to manage molecular/genomic, and non-molecular testing within the Laboratory Management Program. The Laboratory Management Program utilizes evidence-based policies, developed with trained experts, to ensure that the lab services provided to Highmark's members support clinically appropriate care and are medically necessary, in accordance with their benefit policy.
Highmark requires prior authorization for several molecular/genomic tests when performed in an outpatient setting for fully-insured Commercial, Affordable Care Act (ACA) and Medicare Advantage members.
These tests include:
Highmark requires claims review for several non-molecular tests when performed in an outpatient setting for fully insured Commercial, Affordable Care Act (ACA) and Medicare Advantage members. A prior authorization is not required for these tests.
These tests include:
Highmark has adopted eviCore’s molecular/genomic, and non-molecular testing policies. See the PDF below for policies and a complete list of impacted procedure codes.
eviCore has a dedicated webpage for Highmark providers to conveniently access evidence-based clinical guidelines, the current CPT code list, important resources and recent announcements. We encourage you to visit their site to ensure that you have the most current information.
You can also find any updates about the Laboratory Management Program in our provider portal and future issues of Provider News.
eviCore healthcare is an independent company that does not provide Highmark products or services and is solely responsible for the products and services described here.
Related Links
This guide includes a summary of all components of the Laboratory Management Program.
Laboratory Management Program Guide
eviCore Prior Auth Quick Reference Guide
Find additional information and updates in Provider News:
Availity’s multi-payer platform will support the existing payer-provider transactions necessary to manage care for Highmark members.